Statistics Applied to Clinical Trials / (Registro nro. 283891)
[ vista simple ]
| 000 -CABECERA | |
|---|---|
| campo de control de longitud fija | 06238nam a22003975i 4500 |
| 001 - NÚMERO DE CONTROL | |
| campo de control | 283891 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL | |
| campo de control | MX-SnUAN |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN | |
| campo de control | 20160429154257.0 |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL | |
| campo de control de longitud fija | cr nn 008mamaa |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL | |
| campo de control de longitud fija | 150903s2009 ne | o |||| 0|eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO | |
| Número Internacional Estándar del Libro | 9781402095238 |
| -- | 9781402095238 |
| 024 7# - IDENTIFICADOR DE OTROS ESTÁNDARES | |
| Número estándar o código | 10.1007/9781402095238 |
| Fuente del número o código | doi |
| 035 ## - NÚMERO DE CONTROL DEL SISTEMA | |
| Número de control de sistema | vtls000336393 |
| 039 #9 - NIVEL DE CONTROL BIBLIOGRÁFICO Y DETALLES DE CODIFICACIÓN [OBSOLETO] | |
| Nivel de reglas en descripción bibliográfica | 201509030259 |
| Nivel de esfuerzo utilizado para asignar no-encabezamientos de materia en puntos de acceso | VLOAD |
| Nivel de esfuerzo utilizado en la asignación de encabezamientos de materia | 201404300316 |
| Nivel de esfuerzo utilizado para asignar clasificación | VLOAD |
| -- | 201402041348 |
| -- | staff |
| 040 ## - FUENTE DE LA CATALOGACIÓN | |
| Centro catalogador/agencia de origen | MX-SnUAN |
| Lengua de catalogación | spa |
| Centro/agencia transcriptor | MX-SnUAN |
| Normas de descripción | rda |
| 050 #4 - CLASIFICACIÓN DE LA BIBLIOTECA DEL CONGRESO | |
| Número de clasificación | QA276-280 |
| 100 1# - ENTRADA PRINCIPAL--NOMBRE DE PERSONA | |
| Nombre de persona | Cleophas, Ton J. |
| Término indicativo de función/relación | editor. |
| 9 (RLIN) | 308040 |
| 245 10 - MENCIÓN DE TÍTULO | |
| Título | Statistics Applied to Clinical Trials / |
| Mención de responsabilidad, etc. | edited by Ton J. Cleophas, Aeilko H. Zwinderman, Toine F. Cleophas, Eugene P. Cleophas. |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT | |
| Producción, publicación, distribución, fabricación y copyright | Dordrecht : |
| Nombre del de productor, editor, distribuidor, fabricante | Springer Netherlands, |
| Fecha de producción, publicación, distribución, fabricación o copyright | 2009. |
| 300 ## - DESCRIPCIÓN FÍSICA | |
| Extensión | xxii, 562 páginas |
| Otras características físicas | recurso en línea. |
| 336 ## - TIPO DE CONTENIDO | |
| Término de tipo de contenido | texto |
| Código de tipo de contenido | txt |
| Fuente | rdacontent |
| 337 ## - TIPO DE MEDIO | |
| Nombre/término del tipo de medio | computadora |
| Código del tipo de medio | c |
| Fuente | rdamedia |
| 338 ## - TIPO DE SOPORTE | |
| Nombre/término del tipo de soporte | recurso en línea |
| Código del tipo de soporte | cr |
| Fuente | rdacarrier |
| 347 ## - CARACTERÍSTICAS DEL ARCHIVO DIGITAL | |
| Tipo de archivo | archivo de texto |
| Formato de codificación | |
| Fuente | rda |
| 500 ## - NOTA GENERAL | |
| Nota general | Springer eBooks |
| 505 0# - NOTA DE CONTENIDO CON FORMATO | |
| Nota de contenido con formato | Hypotheses, Data, Stratification -- The Analysis Of Efficacy Data -- The Analysis of Safety Data -- Log Likelihood Ratio Tests For Safety Data Analysis -- Equivalence Testing -- Statistical Power And Sample Size -- Interim Analyses -- Controlling The Risk of False Positive Clinical Trials -- Multiple Statistical Inferences -- The Interpretation of The P-Values -- Research Data Closer To Expectation Than Compatible With Random Sampling -- Statistical Tables For Testing Data Closer To Expectation Than Compatible With Random Sampling -- Principles Of Linear Regression -- Subgroup Analysis Using Multiple Linear Regression: Confounding, Interaction, Synergism -- Curvilinear Regression -- Logistic and Cox Regression, Markow Models, Laplace Transformations -- Regression Modeling for Improved Precision -- Post-Hoc Analyses in Clinical Trials, a Case for Logistic Regression Analysis -- Confounding -- Interaction -- Meta-Analysis, Basic Approach -- Meta-Analysis, Review and Update of Methodologies -- Crossover Studies with Continuous Variables -- Crossover Studies with Binary Responses -- Cross-Over Trials Should not be Used to Test Treatments with Different Chemical Class -- Quality-of-Life Assessments in Clinical Trials -- Statistical Analysis of Genetic Data -- Relationship Among Statistical Distributions -- Testing Clinical Trials for Randomness -- Clinical Trials do not Use Random Samples Anymore -- Clinical Data Where Variability is More Important than Averages -- Testing Reproducibility -- Validating Qualitative Diagnostic Tests -- Uncertainty of Qualitative Diagnostic Tests -- Meta-Analysis of Diagnostic Accuracy -- Validating Quantitative Diagnostic Tests -- Summary of Validation Procedures for Diagnostic Tests -- Validating Surrogate Endpoints of Clinical Trials -- Methods for Repeated Measures Analysis -- Advanced Analysis of Variance, Random Effects and Mixed Effects Models -- Monte Carlo Methods -- Physicians’ Daily Life and the Scientific Method -- Clinical Trials: Superiority-Testing -- Trend-Testing -- Odds Ratios and Multiple Regression Models, Why and How to Use Them -- Statistics is no “Bloodless” Algebra -- Bias Due to Conflicts of Interests, Some Guidelines. |
| 520 ## - SUMARIO, ETC. | |
| Sumario, etc. | The previous three editions of this book, rather than having been comprehensive, concentrated on the most relevant aspects of statistical analysis. Although well-received by students, clinicians, and researchers, these editions did not answer all of their questions. This updated and extended edition has been written to serve as a more complete guide and reference-text to students, physicians, and investigators, and, at the same time, preserves the common sense approach to statistical problem-solving of the previous editions. In 1948 the first randomized controlled trial was published by the English Medical Research Council in the British Medical Journal. Until then, observations had been uncontrolled. Initially, trials frequently did not confirm hypotheses to be tested. This phenomenon was attributed to little sensitivity due to small samples, as well as inappropriate hypotheses based on biased prior trials. Additional flaws were being recognized and, subsequently were better accounted for: carryover effects due to insufficient washout from previous treatments, time effects due to external factors and the natural history of the condition under study, bias due to asymmetry between treatment groups, lack of sensitivity due to a negative correlation between treatment responses etc. Such flaws mainly of a technical nature have been largely implemented and lead to trials after 1970 being of significantly better quality than before. The past decade focused, in addition to technical aspects, on the need for circumspection in planning and conducting of clinical trials. As a consequence, prior to approval, clinical trial protocols are now routinely scrutinized by different circumstantial organs, including ethic committees, institutional and federal review boards, national and international scientific organizations, and monitoring committees charged with conducting interim analyses. The present book not only explains classical statistical analyses of clinical trials, but also addresses relatively novel issues, including equivalence testing, interim analyses, sequential analyses, meta-analyses, and provides a framework of the best statistical methods currently available for such purpose. This book is not only useful for investigators involved in the field of clinical trials, but also for students and physicians who wish to better understand the data of trials as published currently. |
| 590 ## - NOTA LOCAL (RLIN) | |
| Nota local | Para consulta fuera de la UANL se requiere clave de acceso remoto. |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA | |
| Nombre de persona | Zwinderman, Aeilko H. |
| Término indicativo de función/relación | editor. |
| 9 (RLIN) | 308041 |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA | |
| Nombre de persona | Cleophas, Toine F. |
| Término indicativo de función/relación | editor. |
| 9 (RLIN) | 308042 |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA | |
| Nombre de persona | Cleophas, Eugene P. |
| Término indicativo de función/relación | editor. |
| 9 (RLIN) | 311734 |
| 710 2# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE ENTIDAD CORPORATIVA | |
| Nombre de entidad corporativa o nombre de jurisdicción como elemento de entrada | SpringerLink (Servicio en línea) |
| 9 (RLIN) | 299170 |
| 776 08 - ENTRADA/ENLACE A UN FORMATO FÍSICO ADICIONAL | |
| Información de relación/Frase instructiva de referencia | Edición impresa: |
| Número Internacional Estándar del Libro | 9781402095221 |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS | |
| Identificador Uniforme del Recurso | <a href="http://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4020-9523-8">http://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4020-9523-8</a> |
| Nota pública | Conectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) | |
| Tipo de ítem Koha | Recurso en línea |
No hay ítems disponibles.